Astrana Health (ASTH) Competitors

$39.16 -0.60 (-1.51%)

Closing price 04:00 PM Eastern

Extended Trading

$39.15 -0.01 (-0.02%)

As of 06:09 PM Eastern

ASTH vs. QBTS, HQY, QMMM, FIGR, and AMTM

Should you buy Astrana Health stock or one of its competitors? MarketBeat compares Astrana Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Astrana Health include D-Wave Quantum (QBTS), HealthEquity (HQY), QMMM (QMMM), Figure Technology Solutions (FIGR), and Amentum (AMTM). These companies are all part of the "business services" industry.

How does Astrana Health compare to D-Wave Quantum?

Astrana Health (NASDAQ:ASTH) and D-Wave Quantum (NYSE:QBTS) are both mid-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Astrana Health has higher revenue and earnings than D-Wave Quantum. D-Wave Quantum is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.53B	0.62	$22.49M	$0.61	64.20
D-Wave Quantum	$24.59M	333.05	-$355.06M	-$1.10	N/A

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 42.5% of D-Wave Quantum shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by company insiders. Comparatively, 3.2% of D-Wave Quantum shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Astrana Health has a net margin of 0.86% compared to D-Wave Quantum's net margin of -2,957.23%. Astrana Health's return on equity of 9.22% beat D-Wave Quantum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
D-Wave Quantum	-2,957.23%	-49.80%	-42.05%

In the previous week, D-Wave Quantum had 29 more articles in the media than Astrana Health. MarketBeat recorded 50 mentions for D-Wave Quantum and 21 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.66 beat D-Wave Quantum's score of 0.38 indicating that Astrana Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	5 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
D-Wave Quantum	11 Very Positive mention(s)	11 Positive mention(s)	15 Neutral mention(s)	6 Negative mention(s)	2 Very Negative mention(s)	Neutral

Astrana Health presently has a consensus price target of $43.14, indicating a potential upside of 10.17%. D-Wave Quantum has a consensus price target of $34.67, indicating a potential upside of 56.58%. Given D-Wave Quantum's stronger consensus rating and higher possible upside, analysts clearly believe D-Wave Quantum is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
D-Wave Quantum	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.76

Astrana Health has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market. Comparatively, D-Wave Quantum has a beta of 1.95, suggesting that its share price is 95% more volatile than the broader market.

Summary

Astrana Health beats D-Wave Quantum on 10 of the 16 factors compared between the two stocks.

How does Astrana Health compare to HealthEquity?

Astrana Health (NASDAQ:ASTH) and HealthEquity (NASDAQ:HQY) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

Astrana Health presently has a consensus price target of $43.14, indicating a potential upside of 10.17%. HealthEquity has a consensus price target of $111.79, indicating a potential upside of 35.79%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87

In the previous week, Astrana Health had 15 more articles in the media than HealthEquity. MarketBeat recorded 21 mentions for Astrana Health and 6 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.36 beat Astrana Health's score of 0.66 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	5 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has lower revenue, but higher earnings than Astrana Health. HealthEquity is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.53B	0.62	$22.49M	$0.61	64.20
HealthEquity	$1.31B	5.29	$215.20M	$2.46	33.46

HealthEquity has a net margin of 16.39% compared to Astrana Health's net margin of 0.86%. HealthEquity's return on equity of 13.86% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
HealthEquity	16.39%	13.86%	8.67%

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by company insiders. Comparatively, 1.5% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Astrana Health has a beta of 0.98, meaning that its share price is 2% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.19, meaning that its share price is 81% less volatile than the broader market.

Summary

HealthEquity beats Astrana Health on 12 of the 17 factors compared between the two stocks.

How does Astrana Health compare to QMMM?

Astrana Health (NASDAQ:ASTH) and QMMM (NASDAQ:QMMM) are both mid-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

In the previous week, Astrana Health had 20 more articles in the media than QMMM. MarketBeat recorded 21 mentions for Astrana Health and 1 mentions for QMMM. QMMM's average media sentiment score of 0.67 beat Astrana Health's score of 0.66 indicating that QMMM is being referred to more favorably in the news media.

Company	Overall Sentiment
Astrana Health	Positive
QMMM	Positive

52.8% of Astrana Health shares are held by institutional investors. 20.3% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Astrana Health has higher revenue and earnings than QMMM.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.53B	0.62	$22.49M	$0.61	64.20
QMMM	$2.70M	2,529.95	-$1.58M	N/A	N/A

Astrana Health has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market. Comparatively, QMMM has a beta of 16.15, indicating that its stock price is 1,515% more volatile than the broader market.

Astrana Health currently has a consensus price target of $43.14, indicating a potential upside of 10.17%. Given Astrana Health's stronger consensus rating and higher possible upside, research analysts plainly believe Astrana Health is more favorable than QMMM.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
QMMM	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Astrana Health has a net margin of 0.86% compared to QMMM's net margin of 0.00%. Astrana Health's return on equity of 9.22% beat QMMM's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
QMMM	N/A	N/A	N/A

Summary

Astrana Health beats QMMM on 11 of the 14 factors compared between the two stocks.

How does Astrana Health compare to Figure Technology Solutions?

Figure Technology Solutions (NASDAQ:FIGR) and Astrana Health (NASDAQ:ASTH) are both mid-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

Astrana Health has a net margin of 0.86% compared to Figure Technology Solutions' net margin of 0.00%. Astrana Health's return on equity of 9.22% beat Figure Technology Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Figure Technology Solutions	N/A	N/A	N/A
Astrana Health	0.86%	9.22%	3.54%

In the previous week, Figure Technology Solutions and Figure Technology Solutions both had 21 articles in the media. Figure Technology Solutions' average media sentiment score of 0.99 beat Astrana Health's score of 0.66 indicating that Figure Technology Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Figure Technology Solutions	11 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Astrana Health	5 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Figure Technology Solutions currently has a consensus target price of $53.63, suggesting a potential upside of 24.07%. Astrana Health has a consensus target price of $43.14, suggesting a potential upside of 10.17%. Given Figure Technology Solutions' higher probable upside, research analysts clearly believe Figure Technology Solutions is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Figure Technology Solutions	2 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.64
Astrana Health	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67

Figure Technology Solutions has higher earnings, but lower revenue than Astrana Health. Astrana Health is trading at a lower price-to-earnings ratio than Figure Technology Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Figure Technology Solutions	$506.86M	15.49	$133.86M	$0.40	108.05
Astrana Health	$3.53B	0.62	$22.49M	$0.61	64.20

52.8% of Astrana Health shares are owned by institutional investors. 26.6% of Figure Technology Solutions shares are owned by insiders. Comparatively, 20.3% of Astrana Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Astrana Health beats Figure Technology Solutions on 8 of the 15 factors compared between the two stocks.

How does Astrana Health compare to Amentum?

Astrana Health (NASDAQ:ASTH) and Amentum (NYSE:AMTM) are both mid-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

Astrana Health has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market. Comparatively, Amentum has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market.

In the previous week, Astrana Health had 8 more articles in the media than Amentum. MarketBeat recorded 21 mentions for Astrana Health and 13 mentions for Amentum. Amentum's average media sentiment score of 0.67 beat Astrana Health's score of 0.66 indicating that Amentum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	5 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amentum	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Amentum has higher revenue and earnings than Astrana Health. Amentum is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.53B	0.62	$22.49M	$0.61	64.20
Amentum	$14.39B	0.39	$66M	$0.60	38.68

Amentum has a net margin of 1.04% compared to Astrana Health's net margin of 0.86%. Amentum's return on equity of 11.74% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
Amentum	1.04%	11.74%	4.78%

Astrana Health presently has a consensus target price of $43.14, indicating a potential upside of 10.17%. Amentum has a consensus target price of $33.18, indicating a potential upside of 42.96%. Given Amentum's higher probable upside, analysts plainly believe Amentum is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
Amentum	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 39.9% of Amentum shares are held by institutional investors. 20.3% of Astrana Health shares are held by insiders. Comparatively, 19.4% of Amentum shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Astrana Health beats Amentum on 8 of the 15 factors compared between the two stocks.

Get Astrana Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASTH vs. The Competition

Export

Metric	Astrana Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.18B	$5.57B	$6.29B	$12.46B
Dividend Yield	N/A	1.56%	2.79%	5.30%
P/E Ratio	64.20	34.69	20.89	25.59
Price / Sales	0.62	22.68	522.17	62.83
Price / Cash	13.86	16.46	42.94	55.34
Price / Book	2.68	3.15	9.86	6.70
Net Income	$22.49M	$218.81M	$3.55B	$333.77M
7 Day Performance	8.54%	-0.05%	-0.32%	0.45%
1 Month Performance	34.71%	3.72%	1.33%	4.06%
1 Year Performance	47.77%	20.19%	41.10%	36.24%

Astrana Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ASTH Astrana Health	2.6683 of 5 stars	$39.16 -1.5%	$43.14 +10.2%	+48.9%	$2.18B	$3.53B	64.20	3,000	Earnings Report Analyst Forecast
QBTS D-Wave Quantum	3.127 of 5 stars	$21.53 +2.9%	$35.53 +65.0%	+99.7%	$7.74B	$24.59M	N/A	3	Trending News Earnings Report Analyst Forecast Gap Down
HQY HealthEquity	4.2204 of 5 stars	$82.63 +0.5%	$111.79 +35.3%	-15.3%	$6.94B	$1.31B	33.59	2,814	Positive News
QMMM QMMM	0.2307 of 5 stars	$119.40 +19.4%	N/A	+10,560.7%	$6.83B	$2.70M	N/A	N/A	High Trading Volume
FIGR Figure Technology Solutions	4.6759 of 5 stars	$37.30 +3.5%	$53.75 +44.1%	N/A	$6.55B	$506.86M	93.25	530	News Coverage Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ASTH) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astrana Health (ASTH) Competitors

ASTH vs. QBTS, HQY, QMMM, FIGR, and AMTM

How does Astrana Health compare to D-Wave Quantum?

Summary

How does Astrana Health compare to HealthEquity?

Summary

How does Astrana Health compare to QMMM?

Summary

How does Astrana Health compare to Figure Technology Solutions?

Summary

How does Astrana Health compare to Amentum?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Astrana Health (ASTH) Competitors

ASTH vs. QBTS, HQY, QMMM, FIGR, and AMTM

How does Astrana Health compare to D-Wave Quantum?

Which has higher valuation & earnings, ASTH or QBTS?

Do institutionals & insiders have more ownership in ASTH or QBTS?

Is ASTH or QBTS more profitable?

Does the media prefer ASTH or QBTS?

Do analysts rate ASTH or QBTS?

Which has more volatility and risk, ASTH or QBTS?

Summary

How does Astrana Health compare to HealthEquity?

Do analysts prefer ASTH or HQY?

Does the media prefer ASTH or HQY?

Which has higher valuation and earnings, ASTH or HQY?

Is ASTH or HQY more profitable?

Do insiders & institutionals believe in ASTH or HQY?

Which has more volatility & risk, ASTH or HQY?

Summary

How does Astrana Health compare to QMMM?

Does the media refer more to ASTH or QMMM?

Do institutionals & insiders have more ownership in ASTH or QMMM?

Which has better earnings and valuation, ASTH or QMMM?

Which has more volatility and risk, ASTH or QMMM?

Do analysts rate ASTH or QMMM?

Is ASTH or QMMM more profitable?

Summary

How does Astrana Health compare to Figure Technology Solutions?

Is FIGR or ASTH more profitable?

Does the media refer more to FIGR or ASTH?

Do analysts prefer FIGR or ASTH?

Which has stronger valuation & earnings, FIGR or ASTH?

Do insiders and institutionals hold more shares of FIGR or ASTH?

Summary

How does Astrana Health compare to Amentum?

Which has more volatility and risk, ASTH or AMTM?

Does the media favor ASTH or AMTM?

Which has preferable valuation and earnings, ASTH or AMTM?

Is ASTH or AMTM more profitable?

Do analysts recommend ASTH or AMTM?

Do insiders & institutionals believe in ASTH or AMTM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools